Can Exparel (liposomal bupivacaine) be used as an intra‑operative field block for a healthy adult female undergoing standard breast augmentation, and what is the appropriate dosing?

Can Exparel Be Used for Breast Augmentation Field Block?

Yes, Exparel (liposomal bupivacaine) can be used as an intra-operative field block for breast augmentation, with a recommended dose of 133 mg (10 mL) expanded to 20 mL with normal saline for pectoral nerve blocks, or up to 266 mg (20 mL) for direct tissue infiltration.

Evidence-Based Dosing and Technique

For Submuscular Breast Augmentation

The most relevant evidence comes from a case report demonstrating ultrasound-guided medial and lateral pectoralis nerve block using liposomal bupivacaine performed before surgical incision 1. This technique resulted in:

• Complete relaxation of the pectoralis major muscle
• Facilitated surgical dissection
• Markedly diminished postoperative pain and muscle spasms

Recommended Dosing Strategy

Based on FDA-approved dosing and breast surgery studies 2:

Option 1: Pectoral Nerve Block (Preferred for submuscular placement)

• Dose: 133 mg (10 mL) expanded with normal saline to 20 mL total volume
• Technique: Ultrasound-guided injection between pectoralis major and minor muscles (PECS-1) and between pectoralis minor and serratus anterior (PECS-2)
• Timing: Pre-incision administration

Option 2: Direct Tissue Infiltration

• Dose: Up to 266 mg (20 mL), can be diluted with up to 10 mL normal saline for 30 mL total
• Technique: Direct infiltration into tissues surrounding the surgical pocket and subcutaneous tissue
• Timing: At conclusion of surgery, prior to closure

Clinical Benefits in Breast Surgery

Recent evidence from breast reconstruction demonstrates significant opioid-sparing effects 3:

• 97.21 mg morphine equivalents with Exparel vs. 160.53 mg with standard bupivacaine
• Fewer total opioid prescriptions (1.35 vs. 1.90)
• Pain reduction most pronounced during postoperative days 1-2 4

Important Safety Considerations

Maximum Dosing

• Maximum single dose: 266 mg (20 mL) for infiltration 2
• Do not exceed FDA-approved maximum doses
• No dose adjustment needed for healthy adults

Duration of Effect

Exparel provides extended analgesia compared to standard bupivacaine 2:

• Systemic plasma levels observed for 96 hours after local infiltration
• 120 hours after nerve blocks
• Peak effect typically within 24-48 hours

Critical Safety Points

1. Do not mix with other local anesthetics - can cause immediate release of bupivacaine from liposomes
2. Administer at least 20 minutes apart if using other local anesthetics
3. Avoid intravascular injection - risk of cardiac toxicity
4. Monitor for Local Anesthetic Systemic Toxicity (LAST) - though no cases reported in dermatologic surgery series of 140 administrations 5

Comparison to Guideline Recommendations

While the PROSPECT guidelines for breast surgery 6 recommend local anesthetic wound infiltration (Grade A) for minor-to-moderate procedures, they evaluated standard bupivacaine, ropivacaine, and lidocaine - not liposomal formulations. The guidelines note that standard local infiltration:

• Reduces pain scores in 4 of 10 trials
• Effect duration limited to 6 hours maximum, never exceeding 24 hours

Exparel extends this duration significantly beyond standard formulations, making it particularly valuable for outpatient breast augmentation where prolonged analgesia improves recovery.

Practical Implementation Algorithm

1. Pre-operative: Administer multimodal analgesia (acetaminophen 1000 mg, NSAID unless contraindicated) 6

2. Intra-operative choice:

   • If submuscular placement: Ultrasound-guided PECS block with 133 mg (10 mL) expanded to 20 mL
   • If subglandular placement: Direct infiltration with up to 266 mg (20 mL)

3. Timing: Pre-incision for nerve blocks; at closure for infiltration

4. Post-operative: Continue acetaminophen and NSAIDs; reserve opioids for breakthrough pain only 6

Common Pitfalls to Avoid

• Mixing with other local anesthetics - causes premature drug release
• Inadequate expansion volume - use full 20 mL for nerve blocks to ensure adequate spread
• Intravascular injection - always aspirate and use ultrasound guidance when possible
• Exceeding maximum dose - 266 mg is the ceiling for single administration

The safety profile is excellent, with adverse events in only 1.5% of cases (mild nausea while on opioids) in dermatologic surgery 5, and comparable safety to standard bupivacaine in breast reconstruction 3, 7.